Open access
1,741
Views
4
CrossRef citations to date
0
Altmetric
Original Article
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014–2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy
Hege KilengDepartment of Clinical Medicine, Gastroenterology and Nutrition Research Group, UiT The Arctic University of Norway, Tromsø, Norway; ;Department of Medicine, University Hospital of North Norway, Tromsø, Norway; View further author information
, Midori KjellinDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; View further author information
, Dario AkaberiDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; View further author information
, Assar BergforsDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; View further author information
, Ann-Sofi DubergDepartment of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; View further author information
, Lars WesslénGävle Hospital, Gävle, Sweden; View further author information
, Astrid DanielssonFalun Hospital, Falun, Sweden; View further author information
, Magnhild Gangsøy KristiansenNordlandssykehuset Bodø, Department of Clinical Medicine (IKM), UiT The Artic University of Tromsø, Norway; View further author information
, Tore GuttebergDepartment of Medical Biology, Research Group for Host-Microbe Interactions, UiT The Arctic University of Norway, Tromsø, Norway; ;Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway; View further author information
, Rasmus GollDepartment of Clinical Medicine, Gastroenterology and Nutrition Research Group, UiT The Arctic University of Norway, Tromsø, Norway; ;Department of Medicine, University Hospital of North Norway, Tromsø, Norway; View further author information
, Anders LannergårdDepartment of Medical Sciences, Section of Infectious Diseases, Uppsala University Hospital, Uppsala, SwedenView further author information
& Johan LennerstrandDepartment of Medical Sciences, Section of Clinical Microbiology, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information
show allView further author information
Pages 1347-1353
|
Received 07 Mar 2018, Accepted 27 Apr 2018, Published online: 05 Nov 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.